Skip to main content

Market Overview

32 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

 

Gainers

Akari Therapeutics, Inc. (NASDAQ: AKTX) shares rose 43.6% to $2.60 during Wednesday's pre-market session. The market cap stands at $28.6 million.

Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares surged 17.9% to $0.28. The market value of their outstanding shares is at $28.3 million.

Kitov Pharma, Inc. (NASDAQ: KTOV) shares increased by 16.5% to $0.92. The market cap stands at $28.5 million.

InMode, Inc. (NASDAQ: INMD) shares moved upwards by 15.1% to $16.11.

Viveve Medical, Inc. (NASDAQ: VIVE) stock increased by 11.7% to $0.14. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.

Jaguar Health, Inc. (NASDAQ: JAGX) shares surged 6.9% to $1.70. The market cap stands at $9.1 million.

Sundial Growers, Inc. (NASDAQ: SNDL) shares rose 5.9% to $11.00. The market cap seems to be at $980.5 million.

Cellect Biotechnology, Inc. (NASDAQ: APOP) stock rose 4.8% to $0.55. The market cap seems to be at $1.6 million.

Owens & Minor, Inc. (NYSE: OMI) stock surged 4.2% to $5.35. The market cap seems to be at $1.9 billion.

Acasti Pharma, Inc. (NASDAQ: ACST) shares increased by 3.6% to $2.00. The market value of their outstanding shares is at $57.6 million. The most recent rating by Oppenheimer, on July 18, is at Outperform, with a price target of $7.00.

Novavax, Inc. (NASDAQ: NVAX) stock increased by 2.3% to $4.40.

NovoCure, Inc. (NASDAQ: NVCR) shares increased by 2.2% to $90.70. The market value of their outstanding shares is at $8.0 billion. According to the most recent rating by SunTrust Robinson Humphrey, on July 29, the current rating is at Buy.

 

Losers

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) stock declined 34.6% to $1.06 during Wednesday's pre-market session. The market cap stands at $5.8 million.

Myriad Genetics, Inc. (NASDAQ: MYGN) stock decreased by 30.2% to $31.10. The market cap stands at $3.3 billion. The most recent rating by Piper Jaffray, on August 14, is at Equal-Weight, with a price target of $40.00.

Oncolytics Biotech, Inc. (NASDAQ: ONCY) shares plummeted 22.2% to $0.70. The market cap seems to be at $23.0 million.

Tilray, Inc. (NASDAQ: TLRY) shares declined 11.7% to $40.65. The market cap stands at $6.3 billion. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.

Intec Pharma, Inc. (NASDAQ: NTEC) stock decreased by 9.7% to $0.51. The market cap seems to be at $250.5 million. According to the most recent rating by H.C. Wainwright, on August 07, the current rating is at Neutral.

Neptune Wellness Solns, Inc. (NASDAQ: NEPT) stock fell 9.1% to $4.50. The market cap stands at $488.3 million.

Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) shares fell 4.7% to $28.90. The most recent rating by Credit Suisse, on August 05, is at Neutral, with a price target of $35.00.

Sesen Bio, Inc. (NASDAQ: SESN) stock plummeted 4.3% to $1.10. The most recent rating by H.C. Wainwright, on June 11, is at Buy, with a price target of $3.00.

Canopy Growth, Inc. (NYSE: CGC) shares plummeted 4.0% to $32.80. The market cap seems to be at $4.2 billion. The most recent rating by Ladenburg Thalmann, on July 17, is at Buy, with a price target of $50.00.

Aphria, Inc. (NYSE: APHA) shares declined 3.9% to $6.64. The market cap seems to be at $1.3 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.

Cronos Group, Inc. (NASDAQ: CRON) shares fell 3.7% to $13.41. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.

Aurora Cannabis, Inc. (NYSE: ACB) stock fell 3.1% to $6.45. The market cap seems to be at $6.4 billion.

Invitae, Inc. (NYSE: NVTA) stock plummeted 3.0% to $25.50.

Teva Pharmaceutical Indus, Inc. (NYSE: TEVA) stock decreased by 3.0% to $6.82. The market cap stands at $7.3 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $9.00.

HEXO, Inc. (NYSE: HEXO) stock fell 2.9% to $4.78. The market value of their outstanding shares is at $1.0 billion. According to the most recent rating by Oppenheimer, on June 25, the current rating is at Perform.

Mustang Bio, Inc. (NASDAQ: MBIO) shares plummeted 2.5% to $3.46. The most recent rating by H.C. Wainwright, on August 13, is at Buy, with a price target of $7.00.

Fresenius Medical Care, Inc. (NYSE: FMS) shares fell 2.3% to $32.71. The market cap stands at $20.2 billion. According to the most recent rating by BTIG, on August 01, the current rating is at Neutral.

SELLAS Life Sciences, Inc. (NASDAQ: SLS) stock fell 2.3% to $0.16. The market cap seems to be at $41.5 million.

Perrigo Co, Inc. (NYSE: PRGO) shares fell 2.1% to $46.77.

Mallinckrodt, Inc. (NYSE: MNK) stock decreased by 2.1% to $4.75. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $11.00.

 

Related Articles (ACST + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com